Literature DB >> 16341802

BAP1 and breast cancer risk.

Isabelle Coupier1, Pierre-Yves Cousin, David Hughes, Patricia Legoix-Né, Alexandra Trehin, Olga M Sinilnikova, Dominique Stoppa-Lyonnet.   

Abstract

BAP1 whose protein interacts with BRCA1 was analysed in a series of 47 French familial breast cancer cases negatively tested for BRCA1/2 mutations. The lack of detection of deleterious mutations suggests that BAP1 is not a high risk breast cancer predisposing gene. However, a common identified variant, rs123602, may be tested in sporadic cases as candidate for moderate risk.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16341802     DOI： 10.1007/s10689-005-2833-4

Source DB:  PubMed          Journal:  Fam Cancer        ISSN： 1389-9600            Impact factor:   2.375


  30 in total

Review 1.  Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1 binding protein BAP1.

Authors:  D E Jensen; F J Rauscher
Journal:  Cancer Lett       Date:  1999-09       Impact factor: 8.679

2.  Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.

Authors:  Federica Casilli; Zorika Christiana Di Rocco; Sophie Gad; Isabelle Tournier; Dominique Stoppa-Lyonnet; Thierry Frebourg; Mario Tosi
Journal:  Hum Mutat       Date:  2002-09       Impact factor: 4.878

3.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Authors:  D E Jensen; M Proctor; S T Marquis; H P Gardner; S I Ha; L A Chodosh; A M Ishov; N Tommerup; H Vissing; Y Sekido; J Minna; A Borodovsky; D C Schultz; K D Wilkinson; G G Maul; N Barlev; S L Berger; G C Prendergast; F J Rauscher
Journal:  Oncogene       Date:  1998-03-05       Impact factor: 9.867

4.  Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium.

Authors:  Deborah Thompson; Csilla I Szabo; Jon Mangion; Rogier A Oldenburg; Fabrice Odefrey; Sheila Seal; Rita Barfoot; Karin Kroeze-Jansema; Dawn Teare; Nazneen Rahman; Hélène Renard; Graham Mann; John L Hopper; Saundra S Buys; Irene L Andrulis; Ruby Senie; Mary B Daly; Dee West; Elaine A Ostrander; Ken Offit; Tamar Peretz; Ana Osorio; J Benitez; Katherine L Nathanson; Olga M Sinilnikova; Edith Olàh; Yves-Jean Bignon; Pablo Ruiz; Michael D Badzioch; Hans F A Vasen; Andrew P Futreal; Catherine M Phelan; Steven A Narod; Henry T Lynch; Bruce A J Ponder; Ros A Eeles; Hanne Meijers-Heijboer; Dominique Stoppa-Lyonnet; Fergus J Couch; Diana M Eccles; D Gareth Evans; Jenny Chang-Claude; Gilbert Lenoir; Barbara L Weber; Peter Devilee; Douglas F Easton; David E Goldgar; Michael R Stratton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

6.  Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

Authors:  T Kainu; S H Juo; R Desper; A A Schaffer; E Gillanders; E Rozenblum; D Freas-Lutz; D Weaver; D Stephan; J Bailey-Wilson; O P Kallioniemi; M Tirkkonen; K Syrjäkoski; T Kuukasjärvi; P Koivisto; R Karhu; K Holli; A Arason; G Johannesdottir; J T Bergthorsson; H Johannsdottir; V Egilsson; R B Barkardottir; O Johannsson; K Haraldsson; T Sandberg; E Holmberg; H Grönberg; H Olsson; A Borg; P Vehmanen; H Eerola; P Heikkila; S Pyrhönen; H Nevanlinna
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

7.  Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3-3p21.3 in sporadic breast-cancer development.

Authors:  D L Buchhagen; L Qiu; P Etkind
Journal:  Int J Cancer       Date:  1994-05-15       Impact factor: 7.396

8.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

9.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  How many more breast cancer predisposition genes are there?

Authors:  D F Easton
Journal:  Breast Cancer Res       Date:  1999-08-23       Impact factor: 6.466
View more
  10 in total

1.  Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.

Authors:  Mohamed H Abdel-Rahman; Robert Pilarski; Colleen M Cebulla; James B Massengill; Benjamin N Christopher; Getachew Boru; Peter Hovland; Frederick H Davidorf
Journal:  J Med Genet       Date:  2011-09-22       Impact factor: 6.318

Review 2.  Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.

Authors:  K Rai; R Pilarski; C M Cebulla; M H Abdel-Rahman
Journal:  Clin Genet       Date:  2015-07-14       Impact factor: 4.438

3.  Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.

Authors:  Shumei Yan; Fan He; Rongzhen Luo; Huini Wu; Mayan Huang; Chunyu Huang; Yong Li; Zhiwei Zhou
Journal:  Tumour Biol       Date:  2015-11-26

4.  Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.

Authors:  Shahram Misaghi; Søren Ottosen; Anita Izrael-Tomasevic; David Arnott; Mohamed Lamkanfi; James Lee; Jinfeng Liu; Karen O'Rourke; Vishva M Dixit; Angus C Wilson
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

5.  Germline BAP1 mutations predispose to renal cell carcinomas.

Authors:  Tatiana Popova; Lucie Hebert; Virginie Jacquemin; Sophie Gad; Virginie Caux-Moncoutier; Catherine Dubois-d'Enghien; Bénédicte Richaudeau; Xavier Renaudin; Jason Sellers; André Nicolas; Xavier Sastre-Garau; Laurence Desjardins; Gabor Gyapay; Virginie Raynal; Olga M Sinilnikova; Nadine Andrieu; Elodie Manié; Antoine de Pauw; Paul Gesta; Valérie Bonadona; Christine M Maugard; Clotilde Penet; Marie-Françoise Avril; Emmanuel Barillot; Odile Cabaret; Olivier Delattre; Stéphane Richard; Olivier Caron; Meriem Benfodda; Hui-Han Hu; Nadem Soufir; Brigitte Bressac-de Paillerets; Dominique Stoppa-Lyonnet; Marc-Henri Stern
Journal:  Am J Hum Genet       Date:  2013-05-16       Impact factor: 11.025

6.  Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.

Authors:  Takashi Hirosawa; Masaharu Ishida; Kentaro Ishii; Keigo Kanehara; Katsuyoshi Kudo; Shinobu Ohnuma; Takashi Kamei; Fuyuhiko Motoi; Takeshi Naitoh; Florin M Selaru; Michiaki Unno
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

7.  Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.

Authors:  Gianluca Tedaldi; Michela Tebaldi; Valentina Zampiga; Ilaria Cangini; Francesca Pirini; Elisa Ferracci; Rita Danesi; Valentina Arcangeli; Mila Ravegnani; Giovanni Martinelli; Fabio Falcini; Paola Ulivi; Daniele Calistri
Journal:  Diagnostics (Basel)       Date:  2020-04-30

8.  BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.

Authors:  Xu-Xiao Chen; Yue Yin; Jian-Wen Cheng; Ao Huang; Bo Hu; Xin Zhang; Yun-Fan Sun; Jian Wang; Yu-Peng Wang; Yuan Ji; Shuang-Jian Qiu; Jia Fan; Jian Zhou; Xin-Rong Yang
Journal:  Cell Death Dis       Date:  2018-10-10       Impact factor: 8.469

Review 9.  Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?

Authors:  Davide Angeli; Samanta Salvi; Gianluca Tedaldi
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

10.  BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.

Authors:  Rong Deng; Yanmin Guo; Lian Li; Jianfeng He; Zhe Qiang; Hailong Zhang; Ran Chen; Yanli Wang; Xian Zhao; Jianxiu Yu
Journal:  Mol Oncol       Date:  2020-11-20       Impact factor: 6.603
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.